We are live on ! Find out more
ATHE icon

Alterity Therapeutics

14 hedge funds and large institutions have $808K invested in Alterity Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 13 → 14 (+1)

0.88% less ownership

Funds ownership: 2.47% → 1.59% (-0.88%)

92% less capital inflows, than outflows

Capital inflows: $42.3K | Capital outflows: $506K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ATHE Hedge Fund Activity: Q3 2021 in Review

14 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2021, worth a combined $808K — down 37% from $1.29M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ATHE positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $22.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $309K sold.

  • 14 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2021, up from 13 in Q2 2021.
  • Funds reported $808K of Alterity Therapeutics stock for Q3 2021, down 37% quarter-over-quarter.
  • 4 funds opened new Alterity Therapeutics positions in Q3 2021 and 3 closed out, a net change of +1 holder.
  • The largest Alterity Therapeutics buyer in Q3 2021 was Two Sigma Securities, an estimated $22.4K added.
  • The largest Alterity Therapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $309K sold.

Based on aggregated 13F filings for Q3 2021.